- Home
- EIX vs BNTX Comparison
EIX vs BNTX Comparison
Compare EIX & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIX | BNTX |
|---|---|---|
| Founded | 1886 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 22.9B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EIX | BNTX |
|---|---|---|
| Price | $57.84 | $89.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 21 |
| Target Price | $63.21 | ★ $116.75 |
| AVG Volume (30 Days) | ★ 4.8M | 993.7K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | ★ 6.14% | N/A |
| EPS Growth | ★ 248.94 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $19,317,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.42 | $0.50 |
| P/E Ratio | $41.95 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $51.10 | $79.81 |
| 52 Week High | $81.62 | $124.00 |
Technical Indicators
Market Signals| Indicator | EIX | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.37 | 40.95 |
| Support Level | $51.71 | $88.05 |
| Resistance Level | $59.96 | $94.18 |
| Average True Range (ATR) | 1.52 | 3.13 |
| MACD | 0.74 | -0.26 |
| Stochastic Oscillator | 95.55 | 18.72 |
Price Performance
Historical ComparisonAbout EIX Edison International
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.